Advanced Therapies Congress 2023

The event unites ATMP-players (ATMP = advanced therapy medicinal products) across the world, to give insight and to promote collaboration to accelerate the development and commercialization of next generation medicines. More than 2,000 attendees from pharma, biotech, research, regulatory bodies, HTAs investment and start-ups are expected to focus on 300 speakers in twelve topic tracks like pricing and market access, gene therapies or rare diseases. In the startup zone, 200 ATMP start-up companies are presenting their work on cutting edge cell and gene therapies, innovative platform technologies and pioneering AI and machine learning solutions.

Our market access managers Dr. Lydia Frick und Dr. Ingo Hantke are looking forward to representing SKC at the event and to exploring the latest topics in ATMPs.

Are you participating at the congress as well? Please do not hesitate to contact us and arrange a personal meeting.

Sources:
Terrapinn: Advanced Therapies Congress